Do analysts recommend AMIX or NXL?

Autonomix Medical currently has a consensus target price of $2.00, suggesting a potential upside of 416.80%. Given Autonomix Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Autonomix Medical is more favorable than Nexalin Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer AMIX or NXL?

In the previous week, Autonomix Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Nexalin Technology. Autonomix Medical's average media sentiment score of 0.98 beat Nexalin Technology's score of 0.94 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nexalin Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AMIX or QNRX?

Autonomix Medical presently has a consensus price target of $2.00, suggesting a potential upside of 416.80%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, AMIX or QNRX?

Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Autonomix Medical N/A N/A -$16.72M -$3.55 N/A Quoin Pharmaceuticals N/A N/A -$15.81M -$29.56 N/A

Is AMIX or QNRX more profitable?

Autonomix Medical's return on equity of -239.36% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% Quoin Pharmaceuticals N/A -489.85% -221.29%

Does the media prefer AMIX or QNRX?

In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.98 beat Quoin Pharmaceuticals' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMIX or SINT?

In the previous week, Autonomix Medical had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Sintx Technologies. Autonomix Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AMIX or VVOS?

In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.98 beat Vivos Therapeutics' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vivos Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Autonomix Medical (AMIX) Competitors

$0.39 -0.01 (-1.28%)

As of 11:43 AM Eastern

Compare

AMIX vs. NXL, LFWD, QNRX, SINT, and VVOS

Should you buy Autonomix Medical stock or one of its competitors? MarketBeat compares Autonomix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Autonomix Medical include Nexalin Technology (NXL), Lifeward (LFWD), Quoin Pharmaceuticals (QNRX), Sintx Technologies (SINT), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry.

How does Autonomix Medical compare to Nexalin Technology?

Autonomix Medical (NASDAQ:AMIX) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Autonomix Medical currently has a consensus target price of $2.00, suggesting a potential upside of 416.80%. Given Autonomix Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Autonomix Medical is more favorable than Nexalin Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Autonomix Medical has a beta of -1.43, indicating that its share price is 243% less volatile than the broader market. Comparatively, Nexalin Technology has a beta of 3.8, indicating that its share price is 280% more volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,018.12%. Nexalin Technology's return on equity of -191.88% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

In the previous week, Autonomix Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Nexalin Technology. Autonomix Medical's average media sentiment score of 0.98 beat Nexalin Technology's score of 0.94 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nexalin Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nexalin Technology has higher revenue and earnings than Autonomix Medical. Nexalin Technology is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Nexalin Technology	$300K	33.20	-$8.22M	-$0.47	N/A

Summary

Autonomix Medical beats Nexalin Technology on 8 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

In the previous week, Lifeward had 10 more articles in the media than Autonomix Medical. MarketBeat recorded 12 mentions for Lifeward and 2 mentions for Autonomix Medical. Lifeward's average media sentiment score of 1.47 beat Autonomix Medical's score of 0.98 indicating that Lifeward is being referred to more favorably in the media.

Company	Overall Sentiment
Lifeward	Positive
Autonomix Medical	Positive

Autonomix Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Autonomix Medical's return on equity of -239.36% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
Autonomix Medical	N/A	-239.36%	-192.46%

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 39.18%. Autonomix Medical has a consensus price target of $2.00, suggesting a potential upside of 416.80%. Given Autonomix Medical's higher possible upside, analysts clearly believe Autonomix Medical is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 1.5% of Lifeward shares are owned by insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Autonomix Medical has lower revenue, but higher earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.92	-$19.91M	-$19.66	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A

Lifeward has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.43, indicating that its share price is 243% less volatile than the broader market.

Summary

Autonomix Medical beats Lifeward on 7 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Autonomix Medical (NASDAQ:AMIX) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Autonomix Medical presently has a consensus price target of $2.00, suggesting a potential upside of 416.80%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.98 beat Quoin Pharmaceuticals' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

Autonomix Medical's return on equity of -239.36% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Autonomix Medical has a beta of -1.43, meaning that its share price is 243% less volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Autonomix Medical beats Quoin Pharmaceuticals on 9 of the 12 factors compared between the two stocks.

How does Autonomix Medical compare to Sintx Technologies?

Autonomix Medical (NASDAQ:AMIX) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Sintx Technologies has higher revenue and earnings than Autonomix Medical. Sintx Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Sintx Technologies	$1.02M	9.68	-$10.36M	-$5.07	N/A

Autonomix Medical has a beta of -1.43, suggesting that its share price is 243% less volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

In the previous week, Autonomix Medical had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Sintx Technologies. Autonomix Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Autonomix Medical presently has a consensus target price of $2.00, indicating a potential upside of 416.80%. Sintx Technologies has a consensus target price of $11.00, indicating a potential upside of 381.40%. Given Autonomix Medical's higher possible upside, research analysts clearly believe Autonomix Medical is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Autonomix Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Autonomix Medical's return on equity of -239.36% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Sintx Technologies	-1,058.60%	-366.49%	-115.04%

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Autonomix Medical beats Sintx Technologies on 8 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Vivos Therapeutics?

Autonomix Medical (NASDAQ:AMIX) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Autonomix Medical has a beta of -1.43, suggesting that its stock price is 243% less volatile than the broader market. Comparatively, Vivos Therapeutics has a beta of 6.1, suggesting that its stock price is 510% more volatile than the broader market.

In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.98 beat Vivos Therapeutics' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vivos Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Autonomix Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -127.70%. Autonomix Medical's return on equity of -239.36% beat Vivos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Vivos Therapeutics	-127.70%	-2,325.64%	-98.12%

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 2.1% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Autonomix Medical currently has a consensus price target of $2.00, suggesting a potential upside of 416.80%. Vivos Therapeutics has a consensus price target of $2.80, suggesting a potential upside of 326.18%. Given Autonomix Medical's higher possible upside, equities analysts plainly believe Autonomix Medical is more favorable than Vivos Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vivos Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Autonomix Medical has higher earnings, but lower revenue than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Vivos Therapeutics	$17.44M	0.52	-$21.17M	-$2.14	N/A

Summary

Autonomix Medical and Vivos Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMIX vs. The Competition

Export

Metric	Autonomix Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.67M	$7.20B	$6.44B	$12.38B
Dividend Yield	N/A	1.23%	2.69%	5.22%
P/E Ratio	-0.11	46.63	23.92	24.33
Price / Sales	N/A	79.20	525.35	120.06
Price / Cash	N/A	24.22	41.34	57.13
Price / Book	0.46	7.39	9.98	6.79
Net Income	-$16.72M	$159.22M	$3.56B	$336.91M
7 Day Performance	-6.75%	0.97%	-0.71%	0.20%
1 Month Performance	N/A	N/A	N/A	-1.56%
1 Year Performance	-76.40%	3.71%	29.11%	33.79%

Autonomix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMIX Autonomix Medical	3.5206 of 5 stars	$0.39 -1.3%	$2.00 +416.8%	-75.5%	$2.67M	N/A	N/A	1	News Coverage Analyst Upgrade
NXL Nexalin Technology	0.3223 of 5 stars	$0.56 +16.4%	N/A	-57.7%	$11.50M	$300K	N/A	3	News Coverage Gap Down
LFWD Lifeward	2.1024 of 5 stars	$7.50 +7.4%	$10.00 +33.3%	-51.5%	$11.46M	$20.92M	N/A	60	Trending News Analyst Revision
QNRX Quoin Pharmaceuticals	1.0942 of 5 stars	$5.00 +3.3%	N/A	-50.3%	$10.05M	N/A	N/A	4	News Coverage
SINT Sintx Technologies	3.068 of 5 stars	$2.29 -5.8%	$11.00 +380.3%	-18.8%	$9.89M	$738K	N/A	40	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMIX) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Autonomix Medical (AMIX) Competitors

AMIX vs. NXL, LFWD, QNRX, SINT, and VVOS

How does Autonomix Medical compare to Nexalin Technology?

Summary

How does Autonomix Medical compare to Lifeward?

Summary

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Summary

How does Autonomix Medical compare to Vivos Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Autonomix Medical (AMIX) Competitors

AMIX vs. NXL, LFWD, QNRX, SINT, and VVOS

How does Autonomix Medical compare to Nexalin Technology?

Do analysts recommend AMIX or NXL?

Do insiders & institutionals hold more shares of AMIX or NXL?

Which has more risk and volatility, AMIX or NXL?

Is AMIX or NXL more profitable?

Does the media prefer AMIX or NXL?

Which has higher earnings & valuation, AMIX or NXL?

Summary

How does Autonomix Medical compare to Lifeward?

Does the media favor LFWD or AMIX?

Is LFWD or AMIX more profitable?

Do analysts recommend LFWD or AMIX?

Do institutionals and insiders hold more shares of LFWD or AMIX?

Which has higher earnings & valuation, LFWD or AMIX?

Which has more risk and volatility, LFWD or AMIX?

Summary

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Do analysts prefer AMIX or QNRX?

Does the media prefer AMIX or QNRX?

Which has higher valuation & earnings, AMIX or QNRX?

Is AMIX or QNRX more profitable?

Which has more risk and volatility, AMIX or QNRX?

Do institutionals and insiders hold more shares of AMIX or QNRX?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Which has higher earnings and valuation, AMIX or SINT?

Which has more volatility and risk, AMIX or SINT?

Does the media favor AMIX or SINT?

Do analysts prefer AMIX or SINT?

Is AMIX or SINT more profitable?

Do institutionals & insiders have more ownership in AMIX or SINT?

Summary

How does Autonomix Medical compare to Vivos Therapeutics?

Which has more volatility and risk, AMIX or VVOS?

Does the media refer more to AMIX or VVOS?

Is AMIX or VVOS more profitable?

Do insiders and institutionals believe in AMIX or VVOS?

Do analysts prefer AMIX or VVOS?

Which has stronger valuation and earnings, AMIX or VVOS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools